Information on this company is supplied by EMIS which is part of Euromoney Institutional Investor plc, one of Europe's largest publishers and a constituent of the FTSE 250 index.
Full name: Bristol Myers Squibb De Mex S.R.L. de C.V.
Previous name(s): E.R. Squibb & Sons de México S.A. de C.V. (2006)
Legal Form: Limited Liability Company
Operational Status: Operational
Incorporation Date: 01-Sep-47
Antibiotics, cardiovascular, dermatological, antacids, analgesics, for the throat and respiratory, oncology and HIV, nutritional supplements.More
Bristol-Myers Squibb S.A. de C.V. is a pharmaceutical company with presence in Mexico since the 40's. The main therapeutic areas it manages in Mexico are: antibiotics, cardiovascular line, OTC medicines and specialized in oncology, HIV and dermatology. Additionally, it owns "Mead Johnson", which is dedicated to the development of nutritional products.More
|Company Tear Sheet|
|NAICS Industry Classification||✓|
|Share Price information||✕|
|Subsidiaries and Affiliates||✓|
|Key Financial Highlights||✕|
|Financial Performance Charts||✕|
|Latest M&A and ECM Deals||✕|
|EMIS Credit Analytics|
|EMIS Benchmark Score||✕|
- or -
EMIS company profiles are part of a larger information service that combines company, industry and country data and analysis for over 120 emerging markets on a unique information platform.
If you need broad and deep coverage of one or many countries, you may be interested in subscribing. Request a demonstration of our full service and one of our account managers will be in touch.